Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix).

[1]  E. Cox,et al.  CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. , 2002, Veterinary immunology and immunopathology.

[2]  L. Babiuk,et al.  CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. , 2001, Antisense & nucleic acid drug development.

[3]  A. Potter,et al.  Cloning and characterization of the gene coding for NADPH-sulfite reductase hemoprotein from Actinobacillus pleuropneumoniae and use of the protein product as a vaccine. , 2001, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[4]  M. Hope,et al.  Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles. , 2001, The Journal of pharmacology and experimental therapeutics.

[5]  D. Klinman,et al.  Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. , 2001, Veterinary microbiology.

[6]  H. Davis.  Use of CpG DNA for enhancing specific immune responses. , 2000, Current topics in microbiology and immunology.

[7]  A. Krieg,et al.  Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. , 1999, Biochimica et biophysica acta.

[8]  S. Tunca,et al.  Immunoadjuvant action of plasmid DNA in liposomes. , 1999, Vaccine.

[9]  A. Krieg,et al.  CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. , 1998, Journal of immunology.

[10]  J. Van Donkersgoed,et al.  A survey of injection site lesions in fed cattle in Canada. , 1997, The Canadian veterinary journal = La revue veterinaire canadienne.

[11]  C. Harding,et al.  CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity , 1997, The Journal of experimental medicine.

[12]  J. Agrewala,et al.  Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells. , 1996, Cytokines and molecular therapy.

[13]  A. Potter,et al.  Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1 , 1993, Infection and immunity.